Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) EPS (Weighted Average and Diluted) (2017 - 2025)

Historic EPS (Weighted Average and Diluted) for CV Sciences (CVSI) over the last 9 years, with Q3 2025 value amounting to -$0.0.

  • CV Sciences' EPS (Weighted Average and Diluted) rose 1713.87% to -$0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.01, marking a year-over-year increase of 1978.9%. This contributed to the annual value of -$0.01 for FY2024, which is 15000.0% down from last year.
  • Latest data reveals that CV Sciences reported EPS (Weighted Average and Diluted) of -$0.0 as of Q3 2025, which was up 1713.87% from -$0.0 recorded in Q2 2025.
  • CV Sciences' 5-year EPS (Weighted Average and Diluted) high stood at $0.04 for Q1 2023, and its period low was -$0.08 during Q4 2021.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.01, with a median of -$0.01 in 2024.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 262787.5% in 2022, then surged by 30000.0% in 2023.
  • CV Sciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.08 in 2021, then soared by 79.6% to -$0.02 in 2022, then surged by 40.32% to -$0.01 in 2023, then surged by 74.98% to -$0.0 in 2024, then increased by 17.14% to -$0.0 in 2025.
  • Its last three reported values are -$0.0 in Q3 2025, -$0.0 for Q2 2025, and -$0.0 during Q1 2025.